Javascript must be enabled to continue!
Rheumatologists’ beliefs about medication barely differ from patients’ medication beliefs
View through CrossRef
Rationale, aims and objectivesStudies suggest that both healthcare providers’ and patients’ beliefs about medication influence medication adherence. This study aims to describe and compare rheumatologists’ and patients’ beliefs about medication. MethodData were collected in a specialized rheumatology clinic in the Netherlands. An adapted version of the Beliefs about Medicines Questionnaire (BMQ) was used to measure beliefs about medication in rheumatologists. (Dichotomized) scores on the BMQ of rheumatologists were compared to RA patients’ scores on the BMQ, using t-tests and two-group tests of proportions with 95% confidence intervals. ResultsTwenty-seven (96% of the eligible) rheumatologists (mean age 42 years, 63% female) and 580 (71% of the eligible) RA patients (mean age 63 years, 68% female) were included. Generally, beliefs about medication did not differ between rheumatologists and patients. Both groups strongly perceived the need to take prescribed medication, but also had significant concerns about the long-term effects of the medication (63% of rheumatologists and 68% of patients expressed concerns). Some differences in beliefs were also present: Fewer rheumatologists worried about the fact that patients have to take medicines (15% versus 44%, respectively) and about the possibility that patients become too dependent on the medicines (15% versus 30%, respectively). ConclusionsThis study indicates that, generally, rheumatologists’ beliefs about medication barely differ from those of patients. However, in some respects, patients do have stronger concerns about medication than rheumatologists. Future research should focus on the interplay between rheumatologists’ and patients’ beliefs about medication and its impact on medication adherence.
Title: Rheumatologists’ beliefs about medication barely differ from patients’ medication beliefs
Description:
Rationale, aims and objectivesStudies suggest that both healthcare providers’ and patients’ beliefs about medication influence medication adherence.
This study aims to describe and compare rheumatologists’ and patients’ beliefs about medication.
MethodData were collected in a specialized rheumatology clinic in the Netherlands.
An adapted version of the Beliefs about Medicines Questionnaire (BMQ) was used to measure beliefs about medication in rheumatologists.
(Dichotomized) scores on the BMQ of rheumatologists were compared to RA patients’ scores on the BMQ, using t-tests and two-group tests of proportions with 95% confidence intervals.
ResultsTwenty-seven (96% of the eligible) rheumatologists (mean age 42 years, 63% female) and 580 (71% of the eligible) RA patients (mean age 63 years, 68% female) were included.
Generally, beliefs about medication did not differ between rheumatologists and patients.
Both groups strongly perceived the need to take prescribed medication, but also had significant concerns about the long-term effects of the medication (63% of rheumatologists and 68% of patients expressed concerns).
Some differences in beliefs were also present: Fewer rheumatologists worried about the fact that patients have to take medicines (15% versus 44%, respectively) and about the possibility that patients become too dependent on the medicines (15% versus 30%, respectively).
ConclusionsThis study indicates that, generally, rheumatologists’ beliefs about medication barely differ from those of patients.
However, in some respects, patients do have stronger concerns about medication than rheumatologists.
Future research should focus on the interplay between rheumatologists’ and patients’ beliefs about medication and its impact on medication adherence.
.
Related Results
Evaluation of Rheumatologists’ Teledermatology Practices and Perspectives
Evaluation of Rheumatologists’ Teledermatology Practices and Perspectives
Objective: In their regular practice, rheumatologists often come across patients with skin and nail abnormalities, so they need dermatology consultations. A new option available to...
NICU Medication Errors: Describing the Cause and Nature of Medication Errors in a NICU in Qatar
NICU Medication Errors: Describing the Cause and Nature of Medication Errors in a NICU in Qatar
IntroductionA medication error can be defined as “any error occurring in the medication use process” and focuses on problems with the delivery of medication to a patient [1]. Medic...
Medication beliefs and adherence– exploring pharmaceutical care interventions and patients’ experiences
Medication beliefs and adherence– exploring pharmaceutical care interventions and patients’ experiences
<strong>Background</strong>
In pharmaceutical care, healthcare professionals collaborate with patients to optimise medication therapy. For patients usin...
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Abstract
Background
Neurogenic thoracic outlet syndrome (nTOS) is the most prevalent subtype of thoracic outlet syndrome and remains one of the most controversial conditions in per...
E002 cs-DMARDs during pregnancy: knowledge and practices of rheumatologists
E002 cs-DMARDs during pregnancy: knowledge and practices of rheumatologists
Abstract
Background/Aims
Conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) remain a cornerstone in managi...
Polish Rheumatologists and Rheumatoid Arthritis Patients Differ in Their Opinions About Treatment Inefficacy
Polish Rheumatologists and Rheumatoid Arthritis Patients Differ in Their Opinions About Treatment Inefficacy
Objectives: This study aims to detect the differences of opinion between rheumatoid arthritis patients and rheumatologists concerning factors affecting escalation of disease modify...
Differences in Rituximab Use Between Pediatric Rheumatologists and Nephrologists for the Treatment of Refractory Lupus Nephritis and Renal Flare in Childhood-Onset Sle
Differences in Rituximab Use Between Pediatric Rheumatologists and Nephrologists for the Treatment of Refractory Lupus Nephritis and Renal Flare in Childhood-Onset Sle
Abstract
Background: Consensus treatment plans have been developed for induction therapy of newly diagnosed proliferative lupus nephritis (LN) in childhood-onset systemic l...
Evaluation of serum taurine level as a biomarker for early diagnosis and follow up of chronic myeloid leukemia
Evaluation of serum taurine level as a biomarker for early diagnosis and follow up of chronic myeloid leukemia
Objective: Investigate serum taurine level as a biomarker for early diagnosis and follow up of chronic myeloid leukemia, find correlation between serum taurine level in different p...

